Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11359870rdf:typepubmed:Citationlld:pubmed
pubmed-article:11359870lifeskim:mentionsumls-concept:C0206745lld:lifeskim
pubmed-article:11359870lifeskim:mentionsumls-concept:C0439849lld:lifeskim
pubmed-article:11359870lifeskim:mentionsumls-concept:C0019425lld:lifeskim
pubmed-article:11359870lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:11359870lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:11359870lifeskim:mentionsumls-concept:C0086376lld:lifeskim
pubmed-article:11359870lifeskim:mentionsumls-concept:C0378126lld:lifeskim
pubmed-article:11359870lifeskim:mentionsumls-concept:C1413554lld:lifeskim
pubmed-article:11359870lifeskim:mentionsumls-concept:C0013682lld:lifeskim
pubmed-article:11359870lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:11359870lifeskim:mentionsumls-concept:C0599283lld:lifeskim
pubmed-article:11359870lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:11359870pubmed:issue4lld:pubmed
pubmed-article:11359870pubmed:dateCreated2001-5-21lld:pubmed
pubmed-article:11359870pubmed:abstractTextHeterozygous CB1 receptor knockout mice were used to examine the effect of reduced CB1 receptor density on G-protein activation in membranes prepared from four brain regions: cerebellum, hippocampus, striatum/globus pallidus (striatum/GP) and cingulate cortex. Results showed that CB1 receptor levels were approximately 50% lower in heterozygous mice in all regions examined. However, maximal stimulation of [(35)S]guanosine-5'-(gamma-O-thio) triphosphate ([(35)S]GTPgammaS) binding by the high efficacy agonist WIN 55,212-2 was reduced by only 20-25% in most brain regions, with the exception of striatum/GP where the decrease in stimulation was as predicted (approximately 50%). Furthermore, although the efficacies of the cannabinoid partial agonists, methanandamide and (9)-tetrahydrocannabinol, were similarly lower in heterozygous mice, their relative efficacies compared with WIN 55,212-2 were generally unchanged. Saturation analysis of net WIN 55,212-2-stimulated [(35)S]GTPgammaS binding showed that decreased stimulation by WIN 55,212-2 in striatum/GP of heterozygous mice was caused by a decrease in the apparent affinity of net-stimulated [(35)S]GTPgammaS binding. The apparent maximal number of binding sites (B(max)) values of net WIN 55,212-2-stimulated [(35)S]GTPgammaS binding were unchanged in cerebellum and striatum/GP of heterozygous mice, but decreased in cingulate cortex, with a similar trend in hippocampus. Moreover, in every region except cingulate cortex, the maximal number of net-stimulated [(35)S]GTPgammaS binding sites per receptor was significantly increased in heterozygous mice. These results indicate region-dependent increases in the apparent efficiency of CB1 receptor-mediated G-protein activation in heterozygous CB1 knockout mice.lld:pubmed
pubmed-article:11359870pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:languageenglld:pubmed
pubmed-article:11359870pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:citationSubsetIMlld:pubmed
pubmed-article:11359870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11359870pubmed:statusMEDLINElld:pubmed
pubmed-article:11359870pubmed:monthMaylld:pubmed
pubmed-article:11359870pubmed:issn0022-3042lld:pubmed
pubmed-article:11359870pubmed:authorpubmed-author:MartinB RBRlld:pubmed
pubmed-article:11359870pubmed:authorpubmed-author:ZimmerAAlld:pubmed
pubmed-article:11359870pubmed:authorpubmed-author:ZimmerA MAMlld:pubmed
pubmed-article:11359870pubmed:authorpubmed-author:SelleyD EDElld:pubmed
pubmed-article:11359870pubmed:authorpubmed-author:BreivogelC...lld:pubmed
pubmed-article:11359870pubmed:authorpubmed-author:RorrerW KWKlld:pubmed
pubmed-article:11359870pubmed:authorpubmed-author:Sim-SelleyL...lld:pubmed
pubmed-article:11359870pubmed:issnTypePrintlld:pubmed
pubmed-article:11359870pubmed:volume77lld:pubmed
pubmed-article:11359870pubmed:ownerNLMlld:pubmed
pubmed-article:11359870pubmed:authorsCompleteYlld:pubmed
pubmed-article:11359870pubmed:pagination1048-57lld:pubmed
pubmed-article:11359870pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:meshHeadingpubmed-meshheading:11359870...lld:pubmed
pubmed-article:11359870pubmed:year2001lld:pubmed
pubmed-article:11359870pubmed:articleTitleAgonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation.lld:pubmed
pubmed-article:11359870pubmed:affiliationDepartment of Pharmacology and Toxicology and Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, Virginia, USA. deselley@hsc.vcu.edulld:pubmed
pubmed-article:11359870pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11359870pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
entrez-gene:12801entrezgene:pubmedpubmed-article:11359870lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11359870lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11359870lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11359870lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11359870lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11359870lld:pubmed